Last date : August 25, 2014The second annual Healthcare Innovation Award is open for nominations of organizations that are practicing innovative approaches for reducing under-5 child mortality. This is a global partnership program of GSK and Save the Children. The organizations that will be judged as practicing most innovative and effective ways to improve the newborn survival will be provided from US$10,000 to US$400,000.
The winners will be promoted through public award announcements and international media coverage to help publicize the winning innovations that are increasing access to healthcare around the world. Major goal of this innovation award is to provide a platform for the innovations and to share information about them so that others interested in improving healthcare for children can learn from, replicate, and adapt these innovations to new environments.
- Nominee can be an organization (public, private, or nonprofit), academic/research institution or healthcare facility.
- Nominee and the innovation must be based in a country classified as low, upper middle or lower middle income by the World Bank.
- Nominees must have created proven and successful results through their innovation in the two years preceding the nomination.
- Nominee cannot be an individual.
- National government bodies may not be nominees, but institutions funded by governments can be nominated.
- The nominations must be made with express permission of the organizers.
- If the eligible innovation is a joint project, more than one eligible organization can be jointly nominated.
- Nominations of more than one eligible innovation from a single eligible organization are also accepted.
- Employees of the Save the Children and GSK, any of their group companies, and any other person directly connected with the HIAs or the Awards cannot be nominated.
- Employees of GSK and Save the Children cannot nominate any organization.
- Nominations can be made by the organization itself or a third-party organization or individual.